Search research articles
Contact Us
Filters
Showing results (1051-1060 of 1,217) with videos related to
Page
of 122
Sort By:
Diabetologia
|
April 21, 2022
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
Simke W Waijer, Priya Vart, David Z I Cherney, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 27, 2020
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health
Allison Tong, Andrew S Levey, Kai-Uwe Eckardt, et al.
European Journal of Heart Failure
|
May 20, 2025
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trial
Stefan D Anker, Michele Robertson, John J V McMurray, et al.
The New England Journal of Medicine
|
November 6, 2012
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis
, Glenn M Chertow, Geoffrey A Block, et al.
Kidney International
|
September 24, 2019
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Thomas H Marwick, Kerstin Amann, Sripal Bangalore, et al.
Kidney International
|
April 17, 2018
Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kai-Uwe Eckardt, Nisha Bansal, Josef Coresh, et al.
Journal of the American Society of Nephrology : JASN
|
October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials
Robert A Fletcher, Niels Jongs, Glenn M Chertow, et al.
Journal of the American Heart Association
|
November 19, 2014
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial
David C Wheeler, Gerard M London, Patrick S Parfrey, et al.
BMJ Open
|
April 22, 2018
Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study
Allison Tong, Sally Crowe, John S Gill, et al.
Journal of the American Society of Nephrology : JASN
|
June 20, 2025
Biomarkers of Kidney Failure and All-Cause Mortality in CKD
Anthony Onoja, Thomas McDonnell, Isabelle Annessi, et al.
Page
of 122
Search research articles
Search
Showing results (1051-1060 of 1,217) with videos related to
Sort By:
Page
of 122
Diabetologia
|
April 21, 2022
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
Simke W Waijer, Priya Vart, David Z I Cherney, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 27, 2020
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health
Allison Tong, Andrew S Levey, Kai-Uwe Eckardt, et al.
European Journal of Heart Failure
|
May 20, 2025
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trial
Stefan D Anker, Michele Robertson, John J V McMurray, et al.
The New England Journal of Medicine
|
November 6, 2012
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis
, Glenn M Chertow, Geoffrey A Block, et al.
Kidney International
|
September 24, 2019
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Thomas H Marwick, Kerstin Amann, Sripal Bangalore, et al.
Kidney International
|
April 17, 2018
Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kai-Uwe Eckardt, Nisha Bansal, Josef Coresh, et al.
Journal of the American Society of Nephrology : JASN
|
October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials
Robert A Fletcher, Niels Jongs, Glenn M Chertow, et al.
Journal of the American Heart Association
|
November 19, 2014
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial
David C Wheeler, Gerard M London, Patrick S Parfrey, et al.
BMJ Open
|
April 22, 2018
Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study
Allison Tong, Sally Crowe, John S Gill, et al.
Journal of the American Society of Nephrology : JASN
|
June 20, 2025
Biomarkers of Kidney Failure and All-Cause Mortality in CKD
Anthony Onoja, Thomas McDonnell, Isabelle Annessi, et al.
Page
of 122